Miroslava Bosheva

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Eric A. F. Simões, Shabir A. Madhi, William J. Muller et al. · The Lancet Child & Adolescent Health · 2023 · 318 citations · Full text

Medicine, Infectious Diseases, Pediatrics +15

Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

Steve Cunningham, Pedro A. Piedra, Federico Martinón‐Torres et al. · The Lancet Respiratory Medicine · 2020 · 132 citations · Full text

Medicine, Infectious Diseases, Pediatrics +15

Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial

Miroslava Bosheva, István Tokodi, Aleksander Krasnow et al. · Frontiers in Nutrition · 2022 · 108 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

Diana Bilton, Tacjana Pressler, Isabelle Fajac et al. · Journal of Cystic Fibrosis · 2019 · 54 citations · Full text

Pharmacy, Microbiology, Pharmaceutics +15

Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season

Ron Dagan, Laura L. Hammitt, Beatriz Seoane Núñez et al. · Journal of the Pediatric Infectious Diseases Society · 2024 · 47 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +13